Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients.
Coco DekkersMehran Alizadeh AghdamMarlies de GraafAndré C KnulstYolanda MeijerJuul M P A van den ReekMarike B StadermannHeike RöckmannPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2021)
This study demonstrates high safety and effectiveness of omalizumab treatment in pediatric patients with CU, which will aid clinical decision making and management of expectations when choosing omalizumab treatment for pediatric patients with CU.